General
Preferred name
FENDILINE HYDROCHLORIDE
Synonyms
Fendiline HCl ()
Fendiline (hydrochloride) ()
P&D ID
PD001904
CAS
113042-18-7
13636-18-5
13042-18-7
Tags
natural product
available
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Potent farnesyltransferase inhibitor; orally bioavailable
(Tocris Bioactive Compound Library)
DESCRIPTION
The hydrochloride salt form of Fendiline, a benzenepropanamine derivative, has been found to be a calcium channel blocker and alpha2-adrenergic receptor antagonist. It could probably restrain the proliferation of tumor cells transformed by K-Ras. IC50: 17
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
9
Axon Medchem Screening Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
MedChem Express Bioactive Compound Library
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
18
Molecular Weight
351.18
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
1
Rotatable Bonds
7
Ring Count
3
Aromatic Ring Count
3
cLogP
5.98
TPSA
12.03
Fraction CSP3
0.22
Chiral centers
1.0
Largest ring
6.0
QED
0.55
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Membrane Transporter/Ion Channel
Neuronal Signaling
Target
Calcium Channel
KRAS inhibitor
Calcium Channel,Ras
Primary Target
Ras GTPases
MOA
Inhibitor
Solubility
DMSO: ≥ 30 mg/mL
Source data
